by Gary Pepper M.D. | Nov 10, 2015 | hormones, Hypothyroidism, T3, thyroid
According to experts, 10 to 20% of hypothyroid individuals fail to respond completely to T4-only (levothyroxine, Synthroid) treatment. Dr. Anthony Bianco, the president of the American Thyroid Association, and his associates believe this is due to genetic variations...
by Gary Pepper M.D. | Oct 30, 2015 | cancer, thyroid, thyroid cancer
By Gary Pepper, M.D. Last week I posted a few highlights from the just concluded International Thyroid Congress. One of the research papers presented at the meeting generated particular concern. Endocrinologists and scientists at UCLA Medical Center led by Dr. Jerome...
by Gary Pepper M.D. | Oct 25, 2015 | metabolism, T3, thyroid
Update from the 15th International Thyroid Congress, Orlando Florida, October, 2015 By Gary Pepper, M.D. Â Â Â Â I just returned from Orlando, Florida, where I attended the 15th International Thyroid Congress and want to provide a report of my experience, to readers...
by Gary Pepper M.D. | Aug 16, 2015 | diet and weight loss, fitness, weight loss
By Gary Pepper, M.D. The views and opinions expressed here are those of the author and may not reflect the opinions of your health professional. Please consult your own doctor before embarking on any new exercise routine. Lack of energy and inability to lose weight...
by Gary Pepper M.D. | Jun 29, 2015 | diabetes, general health & nutrition
by Gary Pepper, M.D. Chances are, if you have diabetes you have heard about a new class of drugs to treat high blood sugar (glucose). The first of these new medications to gain FDA approval in the U.S., in 2013, is Invokana manufactured and promoted by Janssen...
Loading ...